Amgen Agrees to Settle FTC and State Challenges to Horizon Therapeutics Acquisition
- September 01, 2023
Amgen Inc. has reached a proposed consent agreement with the Federal Trade Commission (FTC) and six states to address concerns over the potential competitive harm that would result from the company's $27.8 billion acquisition of Horizon Therapeutics plc, the FTC announced September 1.
ARTICLE TAGS
You must be logged in to access this content.